These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7761140)

  • 41. Failure of penicillin to eradicate group A beta-hemolytic streptococci tonsillitis: causes and management.
    Brook I
    J Otolaryngol; 2001 Dec; 30(6):324-9. PubMed ID: 11771001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.
    Seppälä H; Klaukka T; Vuopio-Varkila J; Muotiala A; Helenius H; Lager K; Huovinen P
    N Engl J Med; 1997 Aug; 337(7):441-6. PubMed ID: 9250845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical and microbiological characteristics of severe infections caused by group A streptococci].
    Hupková H; Zaborská M; Sisovský V; Babál P; Simaljaková M; Koren M; Reis R; Kozáková J
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):164-7. PubMed ID: 25642472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
    Alós JI; Aracil B; Oteo J; Gómez-Garcés JL;
    J Antimicrob Chemother; 2003 Feb; 51(2):333-7. PubMed ID: 12562699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
    Cornaglia G; Ligozzi M; Mazzariol A; Masala L; Lo Cascio G; Orefici G; Fontana R
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S87-92. PubMed ID: 9710676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multi drug resistance in group A hemolytic streptococci in Japan from 1972 to 1977.
    Yamada T; Kosakai N
    Jpn Circ J; 1980 Oct; 44(10):801-3. PubMed ID: 7001083
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
    Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
    Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythromycin resistance genes in Streptococcus pyogenes isolates in Kanagawa, Japan.
    Murase T; Suzuki R; Watanabe Y; Yamai S
    Microbiol Immunol; 2000; 44(10):863-5. PubMed ID: 11128071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina.
    Denamiel G; Llorente P; Carabella M; Rebuelto M; Gentilini E
    J Vet Med B Infect Dis Vet Public Health; 2005 Apr; 52(3):125-8. PubMed ID: 15876224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.
    Betriu C; Sanchez A; Gomez M; Cruceyra A; Picazo JJ
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1717-9. PubMed ID: 8215292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythromycin resistance phenotypes in Swedish clinical isolates of group A streptococci.
    Jasir A; Schalén C
    Adv Exp Med Biol; 1997; 418():443-5. PubMed ID: 9331689
    [No Abstract]   [Full Text] [Related]  

  • 54. The change of macrolide resistance rates in group A Streptococcus isolates from children between 2002 and 2013 in Asahikawa city.
    Sakata H
    J Infect Chemother; 2015 May; 21(5):398-401. PubMed ID: 25618777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
    Koh EH; Kim S; Lee NY
    Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Principles of appropriate antibiotic use for acute pharyngitis in adults: background.
    Cooper RJ; Hoffman JR; Bartlett JG; Besser RE; Gonzales R; Hickner JM; Sande MA;
    Ann Emerg Med; 2001 Jun; 37(6):711-9. PubMed ID: 11385345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decline of erythromycin resistance of group A streptococci in Japan.
    Fujita K; Murono K; Yoshikawa M; Murai T
    Pediatr Infect Dis J; 1994 Dec; 13(12):1075-8. PubMed ID: 7892073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
    Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
    Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group.
    Adam D; Scholz H
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):712-7. PubMed ID: 8922570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children.
    Altamimi S; Khalil A; Khalaiwi KA; Milner RA; Pusic MV; Al Othman MA
    Cochrane Database Syst Rev; 2012 Aug; (8):CD004872. PubMed ID: 22895944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.